Kansikuva

Stability of tetanus toxoid microcapsules

Thesis (M.Sc. in Pharm)--Chulalongkorn University, 1995

Tallennettuna:

Bibliografiset tiedot
Päätekijä:	Krisana Sethpiyanon (Tekijä)
Muut tekijät:	Ubonthip Nimmannit (Avustaja), Vimolmas Lipipun (Avustaja), Chulalongkorn University. Graduate School (Avustaja)
Aineistotyyppi:	Kirja
Julkaistu:	Chulalongkorn University, 2014-02-17T02:50:38Z.
Aiheet:	Thesis
Linkit:	Connect to this object online.
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia

Tetanus toxoid coverage as an indicator of serological protection against neonatal tetanus
Tekijä: Deming Michael S., et al.
Julkaistu: (2002)

Erythema multiforme induced by tetanus toxoid vaccine
Tekijä: Deepa Chaudhary, et al.
Julkaistu: (2020)

Serum Sickness following Tetanus Toxoid Injection
Tekijä: Saja alhawal, et al.
Julkaistu: (2021)

Adverse Effects of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine in 6- to 7-Year-Old Children
Tekijä: Sung-Hsi Wei, et al.
Julkaistu: (2011)

Mass psychogenic illness following tetanus-diphtheria toxoid vaccination in Jordan
Tekijä: Kharabsheh Saad, et al.
Julkaistu: (2001)

Living standard and access to tetanus toxoid immunization among women in Bangladesh
Tekijä: Ummay Nayeema Islam, et al.
Julkaistu: (2022)

Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in India
Tekijä: Hitt J Sharma, et al.
Julkaistu: (2023)

Knowledge and health beliefs of reproductive-age women in Alexandria about tetanus toxoid immunization
Tekijä: Azza Mehanna, et al.
Julkaistu: (2020)

Efficacy and safety of a booster dose of the meningococcal A, C, W, Y-tetanus toxoid conjugate vaccine administered 10 years after primary vaccination and long-term persistence of tetanus toxoid conjugate or polysaccharide vaccine
Tekijä: Beatriz Quiambao, et al.
Julkaistu: (2020)

Immunoadjuvant potential of cross-linked dextran microspheres mixed with chitosan nanospheres encapsulated with tetanus toxoid
Tekijä: Haniyeh Pirouzmand, et al.
Julkaistu: (2017)

Protective doses of tetanus toxoid immunization and its associated factors among mothers in southern Ethiopia
Tekijä: Maycas Gembe, et al.
Julkaistu: (2024)

Faktor-Faktor Yang Berhubungan Dengan Ibu Hamil Dalam Melakukan Imunisasi Tetanus Toxoid
Tekijä: desti widya astuti
Julkaistu: (2022)

Myocarditis following diphtheria, whole-cell pertussis, and tetanus toxoid vaccination in a young infant
Tekijä: Vivek Kumar, et al.
Julkaistu: (2018)

Antibody persistence to diphtheria toxoid, tetanus toxoid, Bordetella pertussis antigens, and Haemophilus influenzae type b following primary and first booster with pentavalent versus hexavalent vaccines
Tekijä: Nasamon Wanlapakorn, et al.
Julkaistu: (2024)

Antenatal visits are positively associated with uptake of tetanus toxoid and intermittent preventive treatment in pregnancy in Ivory Coast
Tekijä: Sanni Yaya, et al.
Julkaistu: (2019)

Increasing Frequency of Antenatal Care Visits May Improve Tetanus Toxoid Vaccination Coverage in Pregnant Women in Pakistan
Tekijä: Sehar Iqbal, et al.
Julkaistu: (2020)

Effect of cash incentives on tetanus toxoid vaccination among rural Nigerian women: a randomized controlled trial
Tekijä: Ryoko Sato, et al.
Julkaistu: (2020)

Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine
Tekijä: C. Panpitpat, et al.
Julkaistu: (2000)

Spatial distribution and associated factors of poor tetanus toxoid immunization among pregnant women in Ethiopia: spatial and multilevel analysis
Tekijä: Desale Bihonegn Asmamaw, et al.
Julkaistu: (2023)

Chitosan-alginate microcapsules of amoxicillin for gastric stability and mucoadhesion
Tekijä: Saahil Arora, et al.
Julkaistu: (2012)

Effect of Temperature on the Stability and Release Profile of Ibuprofen Microcapsules
Tekijä: Issraa R. Abed Al- Rahman
Julkaistu: (2017)

Effect of Temperature on the Stability and Release Profile of Ibuprofen Microcapsules
Tekijä: Issraa R. Abed Al- Rahman
Julkaistu: (2017)

Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy meningococcal vaccine-naïve toddlers: A randomised, controlled trial
Tekijä: Markus Knuf, et al.
Julkaistu: (2022)

A qualitative study on perspectives of pregnant and postnatal mothers on accessing Tetanus Toxoid vaccine in Hai District Kilimanjaro region Tanzania
Tekijä: Asia Hemed Kipengele, et al.
Julkaistu: (2021)

The role of timely initiation of antenatal care on protective dose tetanus toxoid immunization: the case of northern Ethiopia post natal mothers
Tekijä: Muhabaw Shumye Mihret, et al.
Julkaistu: (2018)

Schistosoma mansoni Infection Can Jeopardize the Duration of Protective Levels of Antibody Responses to Immunizations against Hepatitis B and Tetanus Toxoid.
Tekijä: Diana K Riner, et al.
Julkaistu: (2016)

Prevalence and predictors of taking tetanus toxoid vaccine in pregnancy: a cross-sectional study of 8,722 women in Sierra Leone
Tekijä: Sanni Yaya, et al.
Julkaistu: (2020)

A multi-centre, post-marketing surveillance study of Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar TCV®) in India
Tekijä: Raghu Reddy, et al.
Julkaistu: (2022)

Antibody persistence up to 5 y after vaccination with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine in adolescents
Tekijä: Beatriz P. Quiambao, et al.
Julkaistu: (2017)

Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT): A review of the evidence and expert opinion
Tekijä: Silvia Ricci, et al.
Julkaistu: (2023)

A randomized, observer-blind, controlled phase III clinical trial assessing safety and immunological non-inferiority of Vi-diphtheria toxoid versus Vi-tetanus toxoid typhoid conjugate vaccine in healthy volunteers in eastern Nepal
Tekijä: Shipra Chaudhary, et al.
Julkaistu: (2023)

Spatial distribution and determinants of tetanus toxoid immunization among pregnant women in Ethiopia using data from Ethiopian demographic and health survey 2016
Tekijä: Beletech Fentie, et al.
Julkaistu: (2023)

Recommendation for use of diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate, and hepatitis B vaccine in infants
Tekijä: Hye-Kyung Cho, et al.
Julkaistu: (2021)

Factors Associated with the Uptake of Antenatal Tetanus Toxoids Containing Vaccine by First-Time Mothers in Nigeria: Findings from the 2018 Nigerian Demographic Health Survey
Tekijä: Imran Morhason-Bello, et al.
Julkaistu: (2022)

Number of tetanus toxoid injections before birth and associated factors among pregnant women in low and middle income countries: Negative binomial poisson regression
Tekijä: Alebachew Ferede Zegeye, et al.
Julkaistu: (2024)

Coverage and determinants of protective dose tetanus toxoid vaccine among postnatal women delivered at university of Gondar comprehensive specialized hospital, northwest Ethiopia, 2019
Tekijä: Dereje Nibret Gessesse, et al.
Julkaistu: (2021)

Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in healthy toddlers: a Phase II randomized study
Tekijä: Timo Vesikari, et al.
Julkaistu: (2020)

Characterization and stability analysis of metformin HCl microcapsules formulated by complex coacervation technique
Tekijä: Faizan Asad, et al.
Julkaistu: (2023)

Determinants and perceptions of the utilization of tetanus toxoid immunization among reproductive-age women in Dukem Town, Eastern Ethiopia: a community-based cross-sectional study
Tekijä: Meseret Delesa Anatea, et al.
Julkaistu: (2018)

Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age
Tekijä: Gary S. Marshall, et al.
Julkaistu: (2022)